Mass Drug Administration of Azithromycin to Reduce Child Mortality: Only for High-Mortality Settings?
Date
2020-09-01Journal
American Journal of Tropical Medicine and HygienePublisher
American Society of Tropical Medicine and HygieneType
Article
Metadata
Show full item recordIdentifier to cite or link to this item
http://hdl.handle.net/10713/13727ae974a485f413a2113503eed53cd6c53
10.4269/ajtmh.19-0071
Scopus Count
Collections
Related articles
- Efficacy of Mass Azithromycin Distribution for Reducing Childhood Mortality Across Geographic Regions.
- Authors: Porco TC, Oldenburg CE, Arzika AM, Kalua K, Mrango Z, Cook C, Lebas E, Bailey RL, West SK, Oron AP, Keenan JD, Lietman TM, For The Mordor Study Group
- Issue date: 2020 Sep
- Azithromycin to prevent deaths in children.
- Authors: The Lancet Infectious Diseases
- Issue date: 2018 Jun
- One drug to treat them all: ethical implications of the MORDOR trial of mass antibiotic administration to reduce child mortality.
- Authors: Tam CC, Offeddu V, Lim JM, Voo TC
- Issue date: 2019 Jun
- Optimizing the Number of Child Deaths Averted with Mass Azithromycin Distribution.
- Authors: Oldenburg CE, Arzika AM, Maliki R, Lin Y, O'Brien KS, Keenan JD, Lietman TM, For The Mordor Study Group
- Issue date: 2020 Sep
- Mass Oral Azithromycin for Childhood Mortality: Timing of Death After Distribution in the MORDOR Trial.
- Authors: Porco TC, Hart J, Arzika AM, Weaver J, Kalua K, Mrango Z, Cotter SY, Stoller NE, O'Brien KS, Fry DM, Vanderschelden B, Oldenburg CE, West SK, Bailey RL, Keenan JD, Lietman TM, Macrolides Oraux pour Réduire les Décès avec un Oeil sur la Résistance (MORDOR) Study Group
- Issue date: 2019 May 30